Definitions and outcome measures for bullous pemphigoid

Recommendations by an international panel of experts

Dedee F. Murrell, Benjamin S. Daniel, Pascal Joly, Luca Borradori, Masayuki Amagai, Takashi Hashimoto, Frédéric Caux, Branka Marinovic, Animesh A. Sinha, Michael Hertl, Philippe Bernard, David Sirois, Giuseppe Cianchini, Janet A. Fairley, Marcel F. Jonkman, Amit G. Pandya, David Rubenstein, Detlef Zillikens, Aimee S. Payne, David Woodley & 18 others Giovanna Zambruno, Valeria Aoki, Carlo Pincelli, Luis Diaz, Russell P. Hall, Michael Meurer, Jose M. Mascaro, Enno Schmidt, Hiroshi Shimizu, John Zone, Robert Swerlick, Daniel Mimouni, Donna Culton, Jasna Lipozencic, Benjamin Bince, Sergei A. Grando, Jean Claude Bystryn, Victoria P. Werth

Research output: Contribution to journalArticle

Abstract

Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.

Original languageEnglish (US)
Pages (from-to)479-485
Number of pages7
JournalJournal of the American Academy of Dermatology
Volume66
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Bullous Pemphigoid
Outcome Assessment (Health Care)
Therapeutics
Multicenter Studies
Clinical Trials

Keywords

  • bullous pemphigoid
  • consensus
  • definitions
  • outcome measures
  • severity score

ASJC Scopus subject areas

  • Dermatology

Cite this

Definitions and outcome measures for bullous pemphigoid : Recommendations by an international panel of experts. / Murrell, Dedee F.; Daniel, Benjamin S.; Joly, Pascal; Borradori, Luca; Amagai, Masayuki; Hashimoto, Takashi; Caux, Frédéric; Marinovic, Branka; Sinha, Animesh A.; Hertl, Michael; Bernard, Philippe; Sirois, David; Cianchini, Giuseppe; Fairley, Janet A.; Jonkman, Marcel F.; Pandya, Amit G.; Rubenstein, David; Zillikens, Detlef; Payne, Aimee S.; Woodley, David; Zambruno, Giovanna; Aoki, Valeria; Pincelli, Carlo; Diaz, Luis; Hall, Russell P.; Meurer, Michael; Mascaro, Jose M.; Schmidt, Enno; Shimizu, Hiroshi; Zone, John; Swerlick, Robert; Mimouni, Daniel; Culton, Donna; Lipozencic, Jasna; Bince, Benjamin; Grando, Sergei A.; Bystryn, Jean Claude; Werth, Victoria P.

In: Journal of the American Academy of Dermatology, Vol. 66, No. 3, 03.2012, p. 479-485.

Research output: Contribution to journalArticle

Murrell, DF, Daniel, BS, Joly, P, Borradori, L, Amagai, M, Hashimoto, T, Caux, F, Marinovic, B, Sinha, AA, Hertl, M, Bernard, P, Sirois, D, Cianchini, G, Fairley, JA, Jonkman, MF, Pandya, AG, Rubenstein, D, Zillikens, D, Payne, AS, Woodley, D, Zambruno, G, Aoki, V, Pincelli, C, Diaz, L, Hall, RP, Meurer, M, Mascaro, JM, Schmidt, E, Shimizu, H, Zone, J, Swerlick, R, Mimouni, D, Culton, D, Lipozencic, J, Bince, B, Grando, SA, Bystryn, JC & Werth, VP 2012, 'Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, vol. 66, no. 3, pp. 479-485. https://doi.org/10.1016/j.jaad.2011.06.032
Murrell, Dedee F. ; Daniel, Benjamin S. ; Joly, Pascal ; Borradori, Luca ; Amagai, Masayuki ; Hashimoto, Takashi ; Caux, Frédéric ; Marinovic, Branka ; Sinha, Animesh A. ; Hertl, Michael ; Bernard, Philippe ; Sirois, David ; Cianchini, Giuseppe ; Fairley, Janet A. ; Jonkman, Marcel F. ; Pandya, Amit G. ; Rubenstein, David ; Zillikens, Detlef ; Payne, Aimee S. ; Woodley, David ; Zambruno, Giovanna ; Aoki, Valeria ; Pincelli, Carlo ; Diaz, Luis ; Hall, Russell P. ; Meurer, Michael ; Mascaro, Jose M. ; Schmidt, Enno ; Shimizu, Hiroshi ; Zone, John ; Swerlick, Robert ; Mimouni, Daniel ; Culton, Donna ; Lipozencic, Jasna ; Bince, Benjamin ; Grando, Sergei A. ; Bystryn, Jean Claude ; Werth, Victoria P. / Definitions and outcome measures for bullous pemphigoid : Recommendations by an international panel of experts. In: Journal of the American Academy of Dermatology. 2012 ; Vol. 66, No. 3. pp. 479-485.
@article{22f7f7e381874a149fdc8fc57e32d1cc,
title = "Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts",
abstract = "Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.",
keywords = "bullous pemphigoid, consensus, definitions, outcome measures, severity score",
author = "Murrell, {Dedee F.} and Daniel, {Benjamin S.} and Pascal Joly and Luca Borradori and Masayuki Amagai and Takashi Hashimoto and Fr{\'e}d{\'e}ric Caux and Branka Marinovic and Sinha, {Animesh A.} and Michael Hertl and Philippe Bernard and David Sirois and Giuseppe Cianchini and Fairley, {Janet A.} and Jonkman, {Marcel F.} and Pandya, {Amit G.} and David Rubenstein and Detlef Zillikens and Payne, {Aimee S.} and David Woodley and Giovanna Zambruno and Valeria Aoki and Carlo Pincelli and Luis Diaz and Hall, {Russell P.} and Michael Meurer and Mascaro, {Jose M.} and Enno Schmidt and Hiroshi Shimizu and John Zone and Robert Swerlick and Daniel Mimouni and Donna Culton and Jasna Lipozencic and Benjamin Bince and Grando, {Sergei A.} and Bystryn, {Jean Claude} and Werth, {Victoria P.}",
year = "2012",
month = "3",
doi = "10.1016/j.jaad.2011.06.032",
language = "English (US)",
volume = "66",
pages = "479--485",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Definitions and outcome measures for bullous pemphigoid

T2 - Recommendations by an international panel of experts

AU - Murrell, Dedee F.

AU - Daniel, Benjamin S.

AU - Joly, Pascal

AU - Borradori, Luca

AU - Amagai, Masayuki

AU - Hashimoto, Takashi

AU - Caux, Frédéric

AU - Marinovic, Branka

AU - Sinha, Animesh A.

AU - Hertl, Michael

AU - Bernard, Philippe

AU - Sirois, David

AU - Cianchini, Giuseppe

AU - Fairley, Janet A.

AU - Jonkman, Marcel F.

AU - Pandya, Amit G.

AU - Rubenstein, David

AU - Zillikens, Detlef

AU - Payne, Aimee S.

AU - Woodley, David

AU - Zambruno, Giovanna

AU - Aoki, Valeria

AU - Pincelli, Carlo

AU - Diaz, Luis

AU - Hall, Russell P.

AU - Meurer, Michael

AU - Mascaro, Jose M.

AU - Schmidt, Enno

AU - Shimizu, Hiroshi

AU - Zone, John

AU - Swerlick, Robert

AU - Mimouni, Daniel

AU - Culton, Donna

AU - Lipozencic, Jasna

AU - Bince, Benjamin

AU - Grando, Sergei A.

AU - Bystryn, Jean Claude

AU - Werth, Victoria P.

PY - 2012/3

Y1 - 2012/3

N2 - Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.

AB - Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.

KW - bullous pemphigoid

KW - consensus

KW - definitions

KW - outcome measures

KW - severity score

UR - http://www.scopus.com/inward/record.url?scp=84857451523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857451523&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2011.06.032

DO - 10.1016/j.jaad.2011.06.032

M3 - Article

VL - 66

SP - 479

EP - 485

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -